Medi-Caps informs about disclosure

05 Aug 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘LODR Regulations’) with reference to the Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated 13th July, 2023 and SEBI Circular No. SEBI/HO/CFD/CFDPoD2/CIR/P/2024/185 dated December 31, 2024 regarding continuous disclosure requirements for listed entities; Medi-Caps has informed that it enclosed disclosure as required under sub-clause 7 of Para A of Part A of Schedule III on recommendation of the Audit Committee, regarding appointment of Joshi Sahay and Company, Practicing Company Secretaries as Secretarial Auditor of the Company for a period of five consecutive years commencing from FY 2025-2026 till FY 2029-2030, subject to approval of the shareholders of the Company at the ensuing 42nd Annual General Meeting. Disclosure & Brief Profile of Secretarial Auditor is enclosed with this letter. Further, aforesaid disclosure shall also be available on the website of the Company at www.medicaps.com and shall also be submitted in XBRL mode within prescribed time limit. The meeting of the Board of Directors commenced at 3.00 pm and concluded at 03.40 pm.

The above information is a part of company’s filings submitted to BSE.

Medi-Caps Share Price

33.62 -0.03 (-0.09%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×